Literature DB >> 7634923

Treatment and prevention of nosocomial pneumonia.

E Bergogne-Bérézin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7634923     DOI： 10.1378/chest.108.2_supplement.26s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

Review 1.  Optimizing antibiotic therapy in the intensive care unit setting.

Authors:  M H Kollef
Journal:  Crit Care       Date:  2001-06-28       Impact factor: 9.097

2.  Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.

Authors:  C Jaccard; N Troillet; S Harbarth; G Zanetti; D Aymon; R Schneider; R Chiolero; B Ricou; J Romand; O Huber; P Ambrosetti; G Praz; D Lew; J Bille; M P Glauser; A Cometta
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

3.  High Mobility Group Box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice.

Authors:  Vivek S Patel; Ravikumar A Sitapara; Ashwini Gore; Binh Phan; Lokesh Sharma; Vaishali Sampat; Jian Hua Li; Huan Yang; Sangeeta S Chavan; Haichao Wang; Kevin J Tracey; Lin L Mantell
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-18       Impact factor: 6.914

Review 4.  Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy.

Authors:  R G Masterton; A Galloway; G French; M Street; J Armstrong; E Brown; J Cleverley; P Dilworth; C Fry; A D Gascoigne; Alan Knox; Dilip Nathwani; Robert Spencer; Mark Wilcox
Journal:  J Antimicrob Chemother       Date:  2008-04-29       Impact factor: 5.790

5.  Human pathogens abundant in the bacterial metagenome of cigarettes.

Authors:  Amy R Sapkota; Sibel Berger; Timothy M Vogel
Journal:  Environ Health Perspect       Date:  2009-10-22       Impact factor: 9.031

Review 6.  Drug therapy in haemodialysis patients. Special considerations in the elderly.

Authors:  W L St Peter; J L Clark; O M Levos
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 4.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.